PENUMBRA INC. overview

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire ALAMEDA, Calif., Nov. 20, 2024 ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36 th Annual Healthcare Conference on Wednesday, December 4, 2024 . Event: Piper Sandler 36 th Annual Healthcare Conference Date: Wednesday, December 4, 2024 Time: 8:00am ET / 5:00am PT A webcast of the presentation...

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options PR Newswire ALAMEDA, Calif., Nov. 5, 2024 Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum thrombectomy to patients and the...

Penumbra, Inc. Reports Third Quarter 2024 Financial Results PR Newswire ALAMEDA, Calif., Oct. 30, 2024 ALAMEDA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024 . Revenue of $301.0 million in the third quarter of 2024, an increase of 11.1% or 10.9% in constant currency 1 , compared to the third quarter of 2023. U.S. thrombectomy revenue of $162.1 million in...

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke PR Newswire ALAMEDA, Calif., Oct. 14, 2024 ALAMEDA, Calif. , Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc . (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients with acute ischemic stroke. THUNDER is evaluating the safety and efficacy of the company's latest computer assisted vacuum thrombectomy (CAVT™) technology,...

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 PR Newswire ALAMEDA, Calif., Oct. 2, 2024 ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024 at 4:30 PM Eastern Time . A press release with third quarter 2024 financial results will be issued after market close that...

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe PR Newswire ALAMEDA, Calif., Sept. 16, 2024 Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightning Flash™ 2.0 will be the most advanced thrombectomy system on the European market to address venous and...

Penumbra, Inc. to Present at the Baird Global Healthcare Conference PR Newswire ALAMEDA, Calif., Aug. 27, 2024 ALAMEDA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 10, 2024 . Event: Baird Global Healthcare Conference Date: Tuesday, September 10, 2024 Time: 9:05am ET / 6:05am PT A webcast of the presentation can be accessed on the "Events and...

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference PR Newswire ALAMEDA, Calif., Aug. 21, 2024 ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 . Event: Wells Fargo Healthcare Conference Date: Wednesday, September 4, 2024 Time: 2:15pm ET/11:15am PT A webcast of the presentation can be accessed on the "Events and...